Annual Accounts Payable
$2.07 M
-$2.73 M-56.91%
December 31, 2023
Summary
- As of February 7, 2025, ALT annual accounts payable is $2.07 million, with the most recent change of -$2.73 million (-56.91%) on December 31, 2023.
- During the last 3 years, ALT annual accounts payable has risen by +$1.46 million (+238.07%).
- ALT annual accounts payable is now -56.91% below its all-time high of $4.80 million, reached on December 31, 2022.
Performance
ALT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.13 M
-$1.55 M-57.85%
September 30, 2024
Summary
- As of February 7, 2025, ALT quarterly accounts payable is $1.13 million, with the most recent change of -$1.55 million (-57.85%) on September 30, 2024.
- Over the past year, ALT quarterly accounts payable has dropped by -$937.00 thousand (-45.27%).
- ALT quarterly accounts payable is now -86.52% below its all-time high of $8.40 million, reached on June 30, 2010.
Performance
ALT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ALT Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -56.9% | -45.3% |
3 y3 years | +238.1% | +10000.0% |
5 y5 years | +455.1% | +2170.5% |
ALT Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.9% | +1.8% | -78.4% | at low |
5 y | 5-year | -56.9% | >+9999.0% | -78.4% | >+9999.0% |
alltime | all time | -56.9% | >+9999.0% | -86.5% | >+9999.0% |
Altimmune Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.13 M(-57.8%) |
Jun 2024 | - | $2.69 M(-28.5%) |
Mar 2024 | - | $3.76 M(+81.6%) |
Dec 2023 | $2.07 M(-56.9%) | $2.07 M(-32.0%) |
Sep 2023 | - | $3.05 M(-24.5%) |
Jun 2023 | - | $4.04 M(-23.0%) |
Mar 2023 | - | $5.24 M(+9.0%) |
Dec 2022 | $4.80 M(+136.2%) | $4.80 M(+238.5%) |
Sep 2022 | - | $1.42 M(-50.6%) |
Jun 2022 | - | $2.87 M(+30.2%) |
Mar 2022 | - | $2.21 M(+8.4%) |
Dec 2021 | $2.03 M(+232.2%) | $2.03 M(>+9900.0%) |
Sep 2021 | - | $6100.00(-99.6%) |
Jun 2021 | - | $1.42 M(+239.8%) |
Mar 2021 | - | $418.20 K(-31.7%) |
Dec 2020 | $612.30 K(+3264.3%) | $612.30 K(-30.0%) |
Sep 2020 | - | $874.90 K(+348.2%) |
Jun 2020 | - | $195.20 K(-79.0%) |
Mar 2020 | - | $929.60 K(+5007.7%) |
Dec 2019 | $18.20 K(-95.1%) | $18.20 K(-63.5%) |
Sep 2019 | - | $49.90 K(-81.5%) |
Jun 2019 | - | $270.10 K(+1725.0%) |
Mar 2019 | - | $14.80 K(-96.0%) |
Dec 2018 | $372.90 K(+188.8%) | $372.90 K(+147.4%) |
Sep 2018 | - | $150.70 K(-38.5%) |
Jun 2018 | - | $245.20 K(-52.2%) |
Mar 2018 | - | $513.20 K(+297.5%) |
Dec 2017 | $129.10 K(-93.6%) | $129.10 K(-73.9%) |
Sep 2017 | - | $495.10 K(-56.2%) |
Jun 2017 | - | $1.13 M(+34.7%) |
Mar 2017 | - | $839.50 K(-58.1%) |
Dec 2016 | $2.01 M(+284.8%) | $2.01 M(+226.3%) |
Sep 2016 | - | $614.50 K(-13.6%) |
Jun 2016 | - | $711.10 K(+327.3%) |
Mar 2016 | - | $166.40 K(-68.1%) |
Dec 2015 | $521.10 K | $521.10 K(+70.2%) |
Sep 2015 | - | $306.20 K(+46.9%) |
Jun 2015 | - | $208.50 K(-61.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | $537.00 K(+37.2%) |
Dec 2014 | $391.40 K(-65.3%) | $391.40 K(+38.8%) |
Sep 2014 | - | $282.00 K(-35.5%) |
Jun 2014 | - | $437.40 K(-7.3%) |
Mar 2014 | - | $471.80 K(-58.2%) |
Dec 2013 | $1.13 M(-33.5%) | $1.13 M(-2.7%) |
Sep 2013 | - | $1.16 M(-61.3%) |
Jun 2013 | - | $2.99 M(+132.0%) |
Mar 2013 | - | $1.29 M(-24.0%) |
Dec 2012 | $1.70 M(+17.4%) | $1.70 M(-8.1%) |
Sep 2012 | - | $1.85 M(-10.5%) |
Jun 2012 | - | $2.06 M(+46.2%) |
Mar 2012 | - | $1.41 M(-2.4%) |
Dec 2011 | $1.45 M(-53.8%) | $1.45 M(+224.5%) |
Sep 2011 | - | $445.50 K(-82.1%) |
Jun 2011 | - | $2.48 M(-36.7%) |
Mar 2011 | - | $3.92 M(+25.5%) |
Dec 2010 | $3.13 M(+61.7%) | $3.13 M(-53.5%) |
Sep 2010 | - | $6.73 M(-19.9%) |
Jun 2010 | - | $8.40 M(+41.0%) |
Mar 2010 | - | $5.96 M(+208.0%) |
Dec 2009 | $1.93 M(-50.0%) | $1.93 M(+87.7%) |
Sep 2009 | - | $1.03 M(-60.0%) |
Jun 2009 | - | $2.57 M(-24.5%) |
Mar 2009 | - | $3.41 M(-11.9%) |
Dec 2008 | $3.87 M(+177.7%) | $3.87 M(+20.8%) |
Sep 2008 | - | $3.21 M(-13.8%) |
Jun 2008 | - | $3.72 M(+159.4%) |
Mar 2008 | - | $1.43 M(+2.9%) |
Dec 2007 | $1.39 M(+66.1%) | $1.39 M(-21.5%) |
Sep 2007 | - | $1.78 M(+400.5%) |
Mar 2007 | - | $354.70 K(-57.7%) |
Dec 2006 | $839.10 K(>+9900.0%) | $839.10 K(+6612.8%) |
Sep 2006 | - | $12.50 K(-70.7%) |
Jun 2006 | - | $42.70 K(-21.9%) |
Mar 2006 | - | $54.70 K(+681.4%) |
Dec 2005 | $7000.00 | $7000.00(-48.5%) |
Sep 2005 | - | $13.60 K(+202.2%) |
Jun 2005 | - | $4500.00 |
FAQ
- What is Altimmune annual accounts payable?
- What is the all time high annual accounts payable for Altimmune?
- What is Altimmune annual accounts payable year-on-year change?
- What is Altimmune quarterly accounts payable?
- What is the all time high quarterly accounts payable for Altimmune?
- What is Altimmune quarterly accounts payable year-on-year change?
What is Altimmune annual accounts payable?
The current annual accounts payable of ALT is $2.07 M
What is the all time high annual accounts payable for Altimmune?
Altimmune all-time high annual accounts payable is $4.80 M
What is Altimmune annual accounts payable year-on-year change?
Over the past year, ALT annual accounts payable has changed by -$2.73 M (-56.91%)
What is Altimmune quarterly accounts payable?
The current quarterly accounts payable of ALT is $1.13 M
What is the all time high quarterly accounts payable for Altimmune?
Altimmune all-time high quarterly accounts payable is $8.40 M
What is Altimmune quarterly accounts payable year-on-year change?
Over the past year, ALT quarterly accounts payable has changed by -$937.00 K (-45.27%)